Periapical DiseasesROOTCANALNCT06252337
Survival and Success of Two Different Filling Techniques
A study testing bioceramic sealer group in people with Periapical Diseases and Bioceramic Sealers, run by University of Bologna at 1 site in Italy.
Trial summary
This randomized clinical study analysed the clinical use of a new bioceramic premixed CaSi-containing sealer in association with a warm carrier-based technique or a traditional epoxy resin based sealer. Methodology: Healthy patients requiring root canal treatments were enrolled. Read more about this study
- Who is it for?
- Ages 18 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Periapical Diseases, Bioceramic Sealers, Survival Rate
- What is being tested?
- bioceramic sealer group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jan 2023to 30 Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18-75 years
- Healthy status (ASA 1 or 2)
- At least one tooth affected by endodontic pathology (pulpitis, pulp necrosis, re-exacerbated lesions with a previous root canal treatment) (b)
Who cannot join
- Teeth with less than 2 walls of crown structural integrity
- Teeth used as abutments for fixed rehabilitation
- Presence of active periodontal disease (PPD > 4 mm, general BoP > 25% of the sites)
- Wide apexes (>40 diameters) or absence of radiographic pulp chamber
- Any systemic pathology that could compromise bone healing or the immune response (i.e., diabetes)
- Pregnancy or breastfeeding
Show all 9Show fewer
- Heavy smoking (>15 cigarettes/day)
- Exposure to radiation therapy focused on the head and neck region and malignant disease directly involving the jaws.
- Lack of occlusal contacts
Trial locations and contacts
1 site in 1 country.
Italy1 site
Endodontic clinical section, DIBINEM, UNiversity of Bologna
Bologna, 40125
About this study
Official title: Sopravvivenza e Healing Rate di Due Tecniche di Otturazione Canalare: Studio Clinico Randomizzato
This randomized clinical study analysed the clinical use of a new bioceramic premixed CaSi-containing sealer in association with a warm carrier-based technique or a traditional epoxy resin based sealer.
Methodology: Healthy patients requiring root canal treatments were enrolled. Periapical X-rays were taken preoperatively, after root canal filling and after 1, 6, and 12 and 24 months. Two evaluators assessed the Periapical Index (PAI) and the sealer extrusion. The healing rate and survival rate were also evaluated. Barnard test was used to assess the relationship of each potential prognostic factor with periapical index (PAI) at 12-month follow-up. The significance level was set at 0.05.
Read the detailed description
The study was designed in january 2023 as a prospective randomized clinical study. No major modifications were made to the study design after its initial conception. The patients were treated in the Endodontic Clinical Section-Dental Clinic, University of Bologna, by a pool of postgraduate master operators in accordance with standardized protocols and under the strict supervision of the experienced tutors of the master. All the operators, before the study started, were adequately instructed and trained in sealer application and obturation technique. The study was approved by the ethical committee (597-2022-SPER-AUSLBO).
The study adhered to the principles of the Declaration of Helsinki, as modified in 2013. The clinical staff provided written and verbal information to patients before enrolment.
All patients provided a signed informed consent to accept the treatment plan and to follow the hygiene program. The study was designed in compliance with the STROBE checklist and the guidelines published by Dodson in 2007.
Primary Root Canal Treatment Nerve block anaesthesia (1.7 mL, mepivacaine chloridrate, Scandonest 3%, Septodont, St.-Maur-des-Fosses, France) and local anaesthesia (1.8 mL mepivacaine chloridrate, Scandonest 2% with 1:100,000 adrenaline, Septodont, St.-Maur-des-Fosses, France) were performed. The total duration of each endodontic session was 60 to 90 min. Dental dam isolation was positioned on the affected tooth. A straight-line access was performed with a diamond bur mounted on high-speed water-cooled handpieces (Cefla, Imola, Italy). A preoperative working length was estimated using periapical radiographs. The crown-down technique was used. Gates-Glidden burs #2 and #3 were utilised when necessary, only in the coronal third. NiTi instruments were used to shape the canals in the coronal, medium, and apical third (Rotate, VDW, Munchen, Germany). An electronic apex locator (Root ZX, Morita, Osaka, Japan) with K-file #10 was used to determine the working length during the entire clinical procedure. Intra-oral periapical X-rays were performed to confirm the working length during the root canal instrumentation. Each root canal was shaped in the apical third with an apical diameter of #25.04 at least.
Irrigation was performed after the use of each instrument with a total of 5 mL of 5% NaOCl solution (Niclor 5, OGNA, Muggiò, Italy).
Secondary Root Canal Treatment An initial pathway was created with Gates-Glidden burs #3 and #4 (Dentsply Maillefer, Ballaigues, Switzerland) to approximately 3-4 mm depth in the gutta-percha. Reciprocating NiTi instruments (Reciproc Blue, VDW, Munchen, Germany) were then used with Silver Reciproc Endomotor in the "Reciproc All" setting. After each step, the material entrapped among the instrument threads was removed using a sterile sponge. The working length was established after the removal of root canal remnants using periapical X-ray and an electronic apex locator. An apical enlargement was performed with Reciproc Blue #40 and #50 when needed. Irrigation was performed using a total amount of 5.0 mL of 5% NaOCl. When necessary, a dental surgery microscope (OMS3200 Dental Microscope, Zumax Medical Co., Suzhou, China) was used to detect the access to root canal orifices and to identify the presence of remnants.
Root Canal Filling Procedures The randomization was performed before the root canal obturation techniques (1:1 ratio). The operator did not know which sealer was used before that time.
Test Group_ A premixed CaSi-containing bioceramic sealer (Ah Plus Bioceramic, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). AH Plus Bioceramic is mostly composed of zirconium dioxide (50-70%) as a radiopacifier and tricalcium silicate (10-15%) as a bioactive component. Dimethyl sulfoxide and traces of lithium carbonate and thickening agents are also reported by the manufacturer.
The sealer was applied with a sterile K-file inserted into the canal to reach the WL-3 mm and gently moved around the root canal walls. The carrier was heated using a dedicated obturation oven (Thermaprep obturation, Dentsply, Konstanz, Germany) and slowly inserted into the canal at WL-0.5 mm. The excess of the carrier was cut with a round bur.
Control group_ Alternatively, the same protocol was applied with an epoxy resin based sealer.
An X-ray was performed to verify the quality of the root canal obturation. Finally, a small cotton pellet and a temporary restoration (Coltosol, Coltene, Altstaetten, Switzerland) were positioned in the access cavity and maintained until definitive restoration. In case of severe pain, a medical prescription to take NSAID medications (such as ibuprofen or ketoprofen) was prepared by the university staff. In this case, the event was recorded, and the patient was excluded from the study.
Tooth Restoration Teeth were definitely restored within 2 weeks under rubber dam isolation. Temporary restoration was removed using ultrasonic tips, and a crown was restored under rubber dam isolation. Self-etching dentinal bonding agent primer and bonding (Clearfil SE BOND, Kuraray, Osaka, Japan) were applied, photo-cured (Elipar, 3M ESPE, St. Paul, MN, USA) for 30 s and layered by flowable (G_Aenial Flow, GC Corporation, Tokyo, Japan) and composite (G-Aenial, GC Corporation, Tokyo, Japan) resins applied incrementally with 1.5 mm layers.
Radiological Evaluation X-rays were taken after the root canal filling using a parallel technique. The following parameters were used: the target-film distance was approx. 30 cm, 0.41 s exposure at 70 Kw and 8 mA. The radiographs were developed in a standard developer unit at 20 °C (Euronda s.p.a., Vicenza, Italy), 12 s developing time, and 25 s fixing time according to the manufacturer instructions.
Intra-oral periapical X-rays and clinical criteria were used to classify the final outcome, with each patient monitored at 1, 6, 12 and 24 months of follow-up. The root canal obturation was considered "adequate" when the filling material was detected at 0-1.0 mm from the radiological apex. Overfilling, short filling, and sealer extrusion were recorded. X-rays were digitalised using a slide scanner with a mean resolution of 1000 dpi and a magnification factor of 20×.
Periapical Index (PAI) was used to score the preoperative diagnosis and endpoint evaluations, which were evaluated in a double-blind manner by two operators (university researchers trained in this analysis) who did not perform the root canal treatment. PAI calibration was performed using well-defined instructions and periapical radiographs with different periapical lesion scores. To ensure their reliability, the evaluators independently assessed the X-rays. In the event of any discrepancies between their assessments, these were extensively discussed until a mutual consensus was achieved. Sealer extrusion was recorded and measured on each periapical X-ray using open-source software (Image J, Bethesda, MD, USA).
Post-Operative Pain Assessment Post-operative pain was assessed as Patient Reported Outcome (PRO) using a 10 cm Visual Analogical Scale, divided into 0-100 steps, with 0 indicating no pain and 100 indicating the most intense pain. Post-operative pain was evaluated after root canal filling (T0), after 1 day (T1), after 7 days (T7), after 1 month (T28), and after 12 months (T365).
When a tooth presented a PAI 1 or 2, the tooth was considered "radiographically healed".
When a tooth presented an improvement in PAI, the tooth was considered as "radiographically healing".
Statistical Methods Variables were summarised as counts and percentages. Barnard CSM (Convexity, Symmetry, and Minimization) test was used to assess the relationship of each potential prognostic factor with PAI at 12-month follow-up (1-2 [healed] vs. ≥3 [still healing]). Barnard test is an exact unconditional test recommended for association in 2 × 2 tables due to its power and preservation of test size. Operationally, it starts with the most extreme table and sequentially adds more extreme ones based on the smallest p-value calculated by iteratively maximising the probability of a 2 × 2 table. Effect sizes were expressed as differences in percentages with 95% confidence intervals (CIs) derived by matching Barnard CSM p-values.
The 95% CIs for healing and survival rates were obtained with the Bayesian-derived Jeffreys method. The significance level was set at 0.05, and all tests were two-sided. Data analysis was performed with the "Exact" R package.
- Conditions
- Periapical Diseases, Bioceramic Sealers, Survival Rate, Healing Rate
- Being tested
- bioceramic sealer group
- Keywords
- calcium silicate sealers, periapical lesion, endodontic treatment
- Medical subject headings
- Periapical Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
bioceramic sealer groupOther
Also called control group
epoxy resin based + carrier based technique group. The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds.
| Study group | Role | What they receive |
|---|---|---|
| Thermafil AH Plus bioceramic test group | Experimental | Test Group_ A premixed CaSi-containing bioceramic sealer (Ah Plus Bioceramic, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). AH Plus Bioceramic is mostly composed of zirconium dioxide (50-70%) as a radiopacifier and tricalcium silicate (10-15%) as a bioactive component. Dimethyl sulfoxide and traces of lithium carbonate and thickening agents are also reported by the manufacturer.The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds. Receives: Other: bioceramic sealer group |
| Thermafil AH Plus control group | Other | Control Group_ an epoxy resin based sealer (Ah Plus, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds. Receives: Other: bioceramic sealer group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Survival rate
number of teeth still functional at the endline
Measured: 12 months, 24 months
Healing rate
number of teeth with no periapical lesion at the endline using periapical index (PAI)
Measured: 3 months, 6 months 12 months, 24 months
Secondary outcomes (1)
Post operative pain
Analysis of post operative pain using visual analogical scale (VAS). Scale divided into 0-10 steps. 0 = no pain, 10 = most intensive pain
Measured: at the moment of root canal filling, at 1 day, 7 days, 28 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2024
- Study start1 Jan 2023
- Primary completion31 Dec 2025
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Periapical DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Bologna
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fausto Zamparini, University of Bologna
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06252337
- Sponsor's protocol ID
- 597-2022-SPER-AUSLBO - 22064 -
- Acronym
- ROOTCANAL
- Status last verified
- Feb 2026
- First submitted
- 1 Feb 2024
- Last updated
- 27 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Spinelli A, Zamparini F, Lenzi J, Pelliccioni GA, Gandolfi MG, Prati C. Clinical and radiological outcomes of Thermafil Plus used with bioceramic versus epoxy-resin sealer: results from a 12-month randomized clinical trial. Odontology. 2026 Sep 8. doi: 10.1007/s10266-026-01552-8. Online ahead of print.
PubMed 42709313
Study at a glance
From the registry record, last updated by the sponsor on 27 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sopravvivenza e Healing Rate di Due Tecniche di Otturazione Canalare: Studio Clinico Randomizzato
- ClinicalTrials.gov ID
- NCT06252337
- Acronym / sponsor ID
- ROOTCANAL / 597-2022-SPER-AUSLBO - 22064 -
- Conditions
- Periapical Diseases, Bioceramic Sealers, Survival Rate, Healing Rate
- Keywords
- calcium silicate sealers, periapical lesion, endodontic treatment
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- University of BolognaUniversity, hospital or other
- Study start
- 1 Jan 2023 (actual)
- Primary completion
- 31 Dec 2025 (actual)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 9 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized clinical study analysed the clinical use of a new bioceramic premixed CaSi-containing sealer in association with a warm carrier-based technique or a traditional epoxy resin based sealer.
Methodology: Healthy patients requiring root canal treatments were enrolled. Periapical X-rays were taken preoperatively, after root canal filling and after 1, 6, and 12 and 24 months. Two evaluators assessed the Periapical Index (PAI) and the sealer extrusion. The healing rate and survival rate were also evaluated. Barnard test was used to assess the relationship of each potential prognostic factor with periapical index (PAI) at 12-month follow-up. The significance level was set at 0.05.
Detailed description
The study was designed in january 2023 as a prospective randomized clinical study. No major modifications were made to the study design after its initial conception. The patients were treated in the Endodontic Clinical Section-Dental Clinic, University of Bologna, by a pool of postgraduate master operators in accordance with standardized protocols and under the strict supervision of the experienced tutors of the master. All the operators, before the study started, were adequately instructed and trained in sealer application and obturation technique. The study was approved by the ethical committee (597-2022-SPER-AUSLBO).
The study adhered to the principles of the Declaration of Helsinki, as modified in 2013. The clinical staff provided written and verbal information to patients before enrolment.
All patients provided a signed informed consent to accept the treatment plan and to follow the hygiene program. The study was designed in compliance with the STROBE checklist and the guidelines published by Dodson in 2007.
Primary Root Canal Treatment Nerve block anaesthesia (1.7 mL, mepivacaine chloridrate, Scandonest 3%, Septodont, St.-Maur-des-Fosses, France) and local anaesthesia (1.8 mL mepivacaine chloridrate, Scandonest 2% with 1:100,000 adrenaline, Septodont, St.-Maur-des-Fosses, France) were performed. The total duration of each endodontic session was 60 to 90 min. Dental dam isolation was positioned on the affected tooth. A straight-line access was performed with a diamond bur mounted on high-speed water-cooled handpieces (Cefla, Imola, Italy). A preoperative working length was estimated using periapical radiographs. The crown-down technique was used. Gates-Glidden burs #2 and #3 were utilised when necessary, only in the coronal third. NiTi instruments were used to shape the canals in the coronal, medium, and apical third (Rotate, VDW, Munchen, Germany). An electronic apex locator (Root ZX, Morita, Osaka, Japan) with K-file #10 was used to determine the working length during the entire clinical procedure. Intra-oral periapical X-rays were performed to confirm the working length during the root canal instrumentation. Each root canal was shaped in the apical third with an apical diameter of #25.04 at least.
Irrigation was performed after the use of each instrument with a total of 5 mL of 5% NaOCl solution (Niclor 5, OGNA, Muggiò, Italy).
Secondary Root Canal Treatment An initial pathway was created with Gates-Glidden burs #3 and #4 (Dentsply Maillefer, Ballaigues, Switzerland) to approximately 3-4 mm depth in the gutta-percha. Reciprocating NiTi instruments (Reciproc Blue, VDW, Munchen, Germany) were then used with Silver Reciproc Endomotor in the "Reciproc All" setting. After each step, the material entrapped among the instrument threads was removed using a sterile sponge. The working length was established after the removal of root canal remnants using periapical X-ray and an electronic apex locator. An apical enlargement was performed with Reciproc Blue #40 and #50 when needed. Irrigation was performed using a total amount of 5.0 mL of 5% NaOCl. When necessary, a dental surgery microscope (OMS3200 Dental Microscope, Zumax Medical Co., Suzhou, China) was used to detect the access to root canal orifices and to identify the presence of remnants.
Root Canal Filling Procedures The randomization was performed before the root canal obturation techniques (1:1 ratio). The operator did not know which sealer was used before that time.
Test Group_ A premixed CaSi-containing bioceramic sealer (Ah Plus Bioceramic, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). AH Plus Bioceramic is mostly composed of zirconium dioxide (50-70%) as a radiopacifier and tricalcium silicate (10-15%) as a bioactive component. Dimethyl sulfoxide and traces of lithium carbonate and thickening agents are also reported by the manufacturer.
The sealer was applied with a sterile K-file inserted into the canal to reach the WL-3 mm and gently moved around the root canal walls. The carrier was heated using a dedicated obturation oven (Thermaprep obturation, Dentsply, Konstanz, Germany) and slowly inserted into the canal at WL-0.5 mm. The excess of the carrier was cut with a round bur.
Control group_ Alternatively, the same protocol was applied with an epoxy resin based sealer.
An X-ray was performed to verify the quality of the root canal obturation. Finally, a small cotton pellet and a temporary restoration (Coltosol, Coltene, Altstaetten, Switzerland) were positioned in the access cavity and maintained until definitive restoration. In case of severe pain, a medical prescription to take NSAID medications (such as ibuprofen or ketoprofen) was prepared by the university staff. In this case, the event was recorded, and the patient was excluded from the study.
Tooth Restoration Teeth were definitely restored within 2 weeks under rubber dam isolation. Temporary restoration was removed using ultrasonic tips, and a crown was restored under rubber dam isolation. Self-etching dentinal bonding agent primer and bonding (Clearfil SE BOND, Kuraray, Osaka, Japan) were applied, photo-cured (Elipar, 3M ESPE, St. Paul, MN, USA) for 30 s and layered by flowable (G_Aenial Flow, GC Corporation, Tokyo, Japan) and composite (G-Aenial, GC Corporation, Tokyo, Japan) resins applied incrementally with 1.5 mm layers.
Radiological Evaluation X-rays were taken after the root canal filling using a parallel technique. The following parameters were used: the target-film distance was approx. 30 cm, 0.41 s exposure at 70 Kw and 8 mA. The radiographs were developed in a standard developer unit at 20 °C (Euronda s.p.a., Vicenza, Italy), 12 s developing time, and 25 s fixing time according to the manufacturer instructions.
Intra-oral periapical X-rays and clinical criteria were used to classify the final outcome, with each patient monitored at 1, 6, 12 and 24 months of follow-up. The root canal obturation was considered "adequate" when the filling material was detected at 0-1.0 mm from the radiological apex. Overfilling, short filling, and sealer extrusion were recorded. X-rays were digitalised using a slide scanner with a mean resolution of 1000 dpi and a magnification factor of 20×.
Periapical Index (PAI) was used to score the preoperative diagnosis and endpoint evaluations, which were evaluated in a double-blind manner by two operators (university researchers trained in this analysis) who did not perform the root canal treatment. PAI calibration was performed using well-defined instructions and periapical radiographs with different periapical lesion scores. To ensure their reliability, the evaluators independently assessed the X-rays. In the event of any discrepancies between their assessments, these were extensively discussed until a mutual consensus was achieved. Sealer extrusion was recorded and measured on each periapical X-ray using open-source software (Image J, Bethesda, MD, USA).
Post-Operative Pain Assessment Post-operative pain was assessed as Patient Reported Outcome (PRO) using a 10 cm Visual Analogical Scale, divided into 0-100 steps, with 0 indicating no pain and 100 indicating the most intense pain. Post-operative pain was evaluated after root canal filling (T0), after 1 day (T1), after 7 days (T7), after 1 month (T28), and after 12 months (T365).
When a tooth presented a PAI 1 or 2, the tooth was considered "radiographically healed".
When a tooth presented an improvement in PAI, the tooth was considered as "radiographically healing".
Statistical Methods Variables were summarised as counts and percentages. Barnard CSM (Convexity, Symmetry, and Minimization) test was used to assess the relationship of each potential prognostic factor with PAI at 12-month follow-up (1-2 [healed] vs. ≥3 [still healing]). Barnard test is an exact unconditional test recommended for association in 2 × 2 tables due to its power and preservation of test size. Operationally, it starts with the most extreme table and sequentially adds more extreme ones based on the smallest p-value calculated by iteratively maximising the probability of a 2 × 2 table. Effect sizes were expressed as differences in percentages with 95% confidence intervals (CIs) derived by matching Barnard CSM p-values.
The 95% CIs for healing and survival rates were obtained with the Bayesian-derived Jeffreys method. The significance level was set at 0.05, and all tests were two-sided. Data analysis was performed with the "Exact" R package.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Thermafil AH Plus bioceramic test group | Experimental | Other: bioceramic sealer groupTest Group_ A premixed CaSi-containing bioceramic sealer (Ah Plus Bioceramic, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). AH Plus Bioceramic is mostly composed of zirconium dioxide (50-70%) as a radiopacifier and tricalcium silicate (10-15%) as a bioactive component. Dimethyl sulfoxide and traces of lithium carbonate and thickening agents are also reported by the manufacturer.The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds. |
| Thermafil AH Plus control group | Other | Other: bioceramic sealer groupControl Group_ an epoxy resin based sealer (Ah Plus, Dentsply, Konstanz, Germany) was used in association with a warm carrier-based technique (Thermafil, Dentsply, Konstanz, Germany). The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age 18-75 years
- Healthy status (ASA 1 or 2)
- At least one tooth affected by endodontic pathology (pulpitis, pulp necrosis, re-exacerbated lesions with a previous root canal treatment) (b)
Key exclusion criteria (9 listed)
- Teeth with less than 2 walls of crown structural integrity
- Teeth used as abutments for fixed rehabilitation
- Presence of active periodontal disease (PPD > 4 mm, general BoP > 25% of the sites)
- Wide apexes (>40 diameters) or absence of radiographic pulp chamber
- Any systemic pathology that could compromise bone healing or the immune response (i.e., diabetes)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| bioceramic sealer groupAlso: control groupepoxy resin based + carrier based technique group. The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds. | Other | Thermafil AH Plus bioceramic test group, Thermafil AH Plus control group |
Primary outcome
Survival rate
Time frame: 12 months, 24 months
number of teeth still functional at the endline
Healing rate
Time frame: 3 months, 6 months 12 months, 24 months
number of teeth with no periapical lesion at the endline using periapical index (PAI)
1 secondary outcome
Post operative pain
Time frame: at the moment of root canal filling, at 1 day, 7 days, 28 days
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Feb 2026.
- Derived from this study: PubMed 42709313Spinelli A, Zamparini F, Lenzi J, Pelliccioni GA, Gandolfi MG, Prati C. Clinical and radiological outcomes of Thermafil Plus used with bioceramic versus epoxy-resin sealer: results from a 12-month randomized clinical trial. Odontology. 2026 Sep 8. doi: 10.1007/s10266-026-01552-8. Online ahead of print.
- Individual participant dataSharing planned: Undecided
Related trials for Periapical Diseases
Recruiting
Effects of Different Activation Techniques on Antimicrobial Photodynamic Therapy in Apical Periodontitis
Apical Periodontitis, Endodontic Retreatment
Not yet recruiting
Post-operative Pain and Clinical Outcome After Single-cone Obturation With a Calcium Silicate-based Versus Epoxy Resin Sealer
Post Operative Pain, Acute, Irreversible Pulpitis (Toothache)
Not yet recruiting
PRP-Assisted Regenerative Endodontics Versus Conventional Root Canal Treatment in Mature Necrotic Teeth
Pulp Necrosis, Apical Periodontitis
Not yet recruiting
Clinical and Inflammatory Outcomes of Regenerative Endodontic Treatment Using Injectable Platelet-Rich Fibrin in Mature Necrotic Teeth With Chronic Apical Periodontitis.
Chronic Apical Periodontitis, Pulp Necrosis
Active, not recruiting
Early Healing of Apical Periodontitis After Root Canal Treatment With Bioceramic and Calcium Hydroxide Medicaments: Evaluation Using PAI and ImageJ
Apical Periodontitis, Root Canal Treatment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing bioceramic sealer group in people with Periapical Diseases and Bioceramic Sealers, run by University of Bologna at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Survival rate (time frame: 12 months, 24 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06252337, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.